The implementation of buprenorphine/naloxone in college health practice

Journal of American College Health

Volumn 56, Issue 4, 2008, Pages 391-393

  DeMaria Jr , Peter A ^a,c   Patkar, Ashwin A ^b  

^a TEMPLE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Sullivan Hall   (United States)

Author keywords

Buprenorphine; Clinical medicine; Naloxone; Opiate dependence; Other drugs

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; NALOXONE;

ADULT; ARTICLE; CASE REPORT; DRUG COMBINATION; HEALTH SERVICE; HUMAN; MALE; OPIATE ADDICTION; ORGANIZATION AND MANAGEMENT;

ADULT; BUPRENORPHINE; DRUG COMBINATIONS; HUMANS; MALE; NALOXONE; OPIOID-RELATED DISORDERS; STUDENT HEALTH SERVICES;

EID: 41149176951     PISSN: 07448481     EISSN: None     Source Type: Journal    
DOI: 10.3200/JACH.56.44.391-394     Document Type: Article

References (21)

1. Drug Addiction Treatment Act, 42 USC §3502a (2000).
2. Southern Illinois University CORE Institute. Core Survey Web site, http://www.siuc.edu/̃coreinst. Accessed March 3, 2005.
3. Overall teen drug use continues gradual decline, but use of inhalants rises [online press release]. Ann Arbor, MI: University of Michigan News and Information Services; December 21, 2004. http://www.monitoringthefuture.org. Accessed February 28, 2005.
4. McCabe SE, Teter CJ, Boyd CJ. Illicit use of prescription pain medication amongst college students. Drug Alcohol Depend. 2005;77:37-47.
5. Jasinski DR, Pevnick JS, Griffith JD. Human pharmacology and abuse potential of the analgesic buprenorphine. Arch Gen Psych. 1978;35:501-516.
6. Johnson RE, Strain EC, Amass L. Buprenorphine: how to use it right. Drug Alcohol Depend. 2004;70:S59-S77.
7. Johnson RE, Chutuape MA, Strain EC, et al. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N Engl J Med. 2000;343:1290-1297.
8. Ling W, Charuvastra C, Collins JF, et al. Buprenorphine maintenance treatment of opiate dependence: a multicenter randomized clinical trial. Addiction. 1998;93:475-486.
9. Auriacombe M. Deaths attributable to methadone vs buprenorphine in France. JAMA. 2001;284:45.
10. Walsh SL, Eissenberg T. The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic. Drug Alcohol Depend. 2004;70:S13-S27.
11. Mendelson J, Jones RT. Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment? Drug Alcohol Depend. 2003;70:S29-S37.
12. Reckitt Benckiser Pharmaceuticals, Inc. Prescribing information for Suboxone/Subutex. In: Physicians' Desk Reference. Montvale, NJ: Thomson PDR; 2006:2719-2723.
13. Knapp CM, Ciraulo DA, Jaffe J. Opiates: clinical aspects. In: Lowinson JH, Ruiz P, Millman RB, Langrod JG, eds. Substance Abuse: A Comprehensive Textbook. 4th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2005:185-192.
14. Collins ED, Kleber HD. Opioids: detoxification. In: Galanter M, Kleber HD, eds. The American Psychiatric Publishing Textbook of Substance Abuse Treatment. 3rd ed. Washington, DC: American Psychiatric Publishing: 2004:265-289.
15. Gerstein DR. Outcome research: drug abuse. In: Galanter M, Kleber HD, eds. The American Psychiatric Publishing Textbook of Substance Abuse Treatment. 3rd ed. Washington, DC: American Psychiatric Publishing; 2004:137-157.
16. Fiellin DA, Rosenheck RA, Kosten TR. Office-based treatments for opiate dependence: reaching new patient populations. Am J Psych. 2001;158:1200-1204.
17. Center for Substance Abuse Treatment Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series #40. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2004. DHHS Publication No. (SMA) 04-3939. http://buprenorphine.samhsa.gov/Bup%20guidelines.pdf. Accessed November 29, 2007.
18. Mohler-Kuo M, Lee JE, Wechsler H. Trends in marijuana and other illicit drug use among college students: results from 4 Harvard School of Public Health college alcohol study surveys: 1993-2001. J Am Coll Health. 2003;52:17-24.
19. Brooner RK, King VL, Kidorf M, et al. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psych. 1997;54:71.
20. Fiellin DA, Kleber H, Trumble-Hejduk JG, et al. Consensus statement on office-based treatment of opioid dependence using buprenorphine. J Subst Abuse Treat. 2004:27;153-159.
21. O'Brien CP, Kampman KM. Opioids, antagonists and partial agonists. In: Galanter M, Kleber HD, eds. The American Psychiatric Publishing Textbook of Substance Abuse Treatment. 3rd ed. Washington, DC: American Psychiatric Publishing; 2004:305-319.